Antitumor activity of triazine mimic antibiotics for DNA-binding implications (impressive activity in vitro against a variety of tumor types in the NCI-60 screen): NSC 710607 to fight HCT-116 human colon carcinoma cell lines in vivo using the hollow fiber assay and xenograft mouse models-Reference-Cited by-同舟云学术

Antitumor activity of triazine mimic antibiotics for DNA-binding implications (impressive activity in vitro against a variety of tumor types in the NCI-60 screen): NSC 710607 to fight HCT-116 human colon carcinoma cell lines in vivo using the hollow fiber assay and xenograft mouse models

Published:2023-02-13 Issue:9 Volume:149 Page:6501-6511
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Spychala Jaroslaw^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04604-6.pdf

Reference34 articles.

1. Boykin DW, Kumar A, Spychala J, Zhou M, Lombardy RJ, Wilson WD, Dykstra CC, Jones SK, Hall JE, Tidwell RR, Laughton C, Nunn CM, Neidle S (1995) Dicationic diarylfurans as anti-Pneumocystis carinii agents. J Med Chem 38:912–916. https://doi.org/10.1021/jm00006a009

2. Burden DA, Osheroff N (1998) Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1400:139–154. https://doi.org/10.1016/s0167-4781(98)00132-8

3. Coleman LW, Rohr LR, Bronstein IB, Holden JA (2002) Human DNA topoisomerase I: an anticancer drug target present in human sarcomas. Hum Pathol 33:599–607. https://doi.org/10.1053/hupa.2002.124911

4. Dowling CM, Claffey J, Cuffe S, Fichtner I, Pampillon C, Sweeney NJ, Strohfeldt K, Watson RWG, Tacke M (2008) Antitumor activity of titanocene Y in xenografted PC3 tumors in mice. Lett Drug Des Disc 5:141–144. https://doi.org/10.2174/157018008783928463

5. Gu W, Li Y, Xia Y-Z, Yan T, Yang M-H, Kong L-Y (2022) Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine. Nat Commun. https://doi.org/10.1038/s41467-022-33761-4